Horsham, United Kingdom

John P Clayton

This inventor holds 37 USPTO granted patents, primarily in Antibacterial Compounds. Top assignee: Beecham Group Plc. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John P Clayton. Retrieved from https://idiyas.com/inventor/john-p-clayton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 97(Granted Patents)


Location History:

  • Horsham, EN (1976 - 1978)
  • Horsham, GB (1978 - 1985)

Company Filing History:


Years Active: 1976-1985

Loading Chart...
Areas of Expertise:
Antibacterial Compounds
Penicillins
Cephalosporins
Chemical Intermediates
Infection Treatment
Lactonyl Esters
Ketenimine Compounds
Organic Compounds
Phthalidyl Esters
Aminoalkyl Esters
Isocyanocephalosporanates
Monoesters
37 patents (USPTO):Explore Patents

Title: John P Clayton: Innovator in Pharmaceutical Compositions

Introduction

John P Clayton is a notable inventor based in Horsham, GB, recognized for his substantial contributions to the field of pharmaceuticals. With 37 patents to his name, Clayton has made significant advancements that have impacted antibacterial treatments.

Latest Patents

Among his latest patents, Clayton’s work includes a synergistic combination that involves clavulanic acid and other active compounds designed to enhance antibacterial efficacy. Specifically, one of his recent patents details pharmaceutical compositions that leverage a synergistically effective amount of clavulanic acid or its pharmaceutically acceptable salts combined with specific compounds to improve treatment outcomes. Another patent showcases the development of antibacterial compounds, particularly esters derived from what he terms 'monic acid,' demonstrating effectiveness against both Gram-positive and Gram-negative organisms.

Career Highlights

John P Clayton’s professional journey is intertwined with his role at Beecham Group Plc, a company where he has been able to channel his expertise in pharmaceuticals into innovative solutions. His prolific output of patents speaks to his commitment to advancing medical science and addressing the ever-evolving challenges presented by bacterial infections.

Collaborations

In his inventive pursuits, Clayton has collaborated with esteemed colleagues, including Norman H Rogers and Kong Luk. Their combined expertise has fostered a productive environment for developing groundbreaking pharmaceutical solutions.

Conclusion

John P Clayton stands out as an influential figure in the realm of pharmaceutical innovation. His array of patents not only highlights his ingenuity but also his dedication to improving healthcare outcomes through scientific advancements. With continued collaboration and research, Clayton remains a significant contributor to the fight against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…